BIOS
Closed
Bioplus Acquisition Corp
10.795
0.000 (0.00%)
Last Update: 13 Oct 2023 16:30:00
Yesterday: 10.795
Day's Range: 10.795 - 10.795
Send
sign up or login to leave a comment!
When Written:
10.44
BioPlus Acquisition Corp is a special purpose acquisition company (SPAC) that was formed in 2021. The company's goal is to acquire a biopharmaceutical or life sciences company that is focused on developing innovative therapies for unmet medical needs. BioPlus Acquisition Corp is led by Chairman and CEO Dr. James Sapirstein, who has over 35 years of experience in the pharmaceutical industry. The company raised $200 million in its initial public offering (IPO) and is listed on the NASDAQ under the ticker symbol "BPMC." As a SPAC, BioPlus Acquisition Corp has a two-year window to identify and acquire a target company, after which it must return the funds to its investors if no acquisition is made.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








